Hospital or health organisation · founded 1899
National Jewish Health
Denver, United States · nationaljewish.org
- Citations, last 5 years
- 32.7k
- Works, last 5 years
- 3 582
- h-index
- 613
- Scientists listed
- 215
- Grants since 2016
- 246
Grants received
2018–2024 · research · R01
Regulation of Gene Expression in the anaphylactic Pathway
Hua Huang · National Jewish Health · funded by National Institutes of Health
2018–2022 · research · R01
A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis
Nabeel Hamzeh · National Jewish Health · funded by National Institutes of Health
2018–2023 · research · R01
Biomarker of Lung Disease in African Americans
Russell Paul Bowler · National Jewish Health · funded by National Institutes of Health
2018–2023 · research · R01
Regulation of Gene Expression in the anaphylactic Pathway
Hua Huang · National Jewish Health · funded by National Institutes of Health
2018–2023 · career development · K08
Mannose binding lectin-dependent complement activation in emphysema
Karina Serban · National Jewish Health · funded by National Institutes of Health
2018–2021 · career development · K23
Genomic Analysis of Epithelial Growth and Repair Mechanisms in Aspirin Exacerbated Respiratory Disease
Brian David Modena · National Jewish Health · funded by National Institutes of Health
2018–2023 · research · R01
Neutrophil Nox2 controls mononuclear cell functions in inflammation; role in CGD
Donna L Bratton · National Jewish Health · funded by National Institutes of Health
2018–2021 · research · R01
Fibroblast Resistance to Apoptosis in Pulmonary Fibrosis
David W. Riches · National Jewish Health · funded by National Institutes of Health
2018–2023 · career development · K08
Mannose binding lectin-dependent complement activation in emphysema
Karina Serban · National Jewish Health · funded by National Institutes of Health
2018–2022 · cooperative agreement · U01
Treatment of CGD with the PPAR-gamma agonist, pioglitazone, enhances phagocyte anti-inflammatory and antimicrobial responses
Donna L Bratton · National Jewish Health · funded by National Institutes of Health
2018–2021 · research · R01
Lung MSC regulate angiogenesis and repair during fibrosis
Susan M Majka · National Jewish Health · funded by National Institutes of Health
2018–2023 · research · R01
A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis
Nabeel Hamzeh · National Jewish Health · funded by National Institutes of Health
2018–2023 · career development · K08
Metabolic Reprogramming of Recruited Alveolar Macrophages by Arginine In Acute Lung Injury
Kara J Mould · National Jewish Health · funded by National Institutes of Health
2018–2024 · cooperative agreement · U01
Optimization of AEOL10150 treatment of sulfur mustard-induced lung toxidrome in a pig model
Brian J Day · National Jewish Health · funded by National Institutes of Health
2018–2020 · research · R21
The Effects of MHCI Heterozygosity on T Cell Receptor Repertoires
Philippa C. Marrack · National Jewish Health · funded by National Institutes of Health
2018–2023 · research · R01
Epigenetic Regulation of Immune Pathways in Sarcoidosis
Lisa A Maier · National Jewish Health · funded by National Institutes of Health
2018–2025 · research · R35
Lung Macrophage Programming in Acute Lung Injury
William Janssen · National Jewish Health · funded by National Institutes of Health
2018–2022 · research · R01
Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma
Hong W Chu · National Jewish Health · funded by National Institutes of Health
2018–2023 · career development · K08
Mannose binding lectin-dependent complement activation in emphysema
Karina Serban · National Jewish Health · funded by National Institutes of Health
2018–2025 · cooperative agreement · UH3
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis
Gregory Paul Downey · National Jewish Health · funded by National Institutes of Health
2018–2023 · career development · K08
Modulating macrophage-mediated Inflammation in cystic fibrosis
Katherine B Hisert · National Jewish Health · funded by National Institutes of Health
2018–2022 · research · R01
A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary Sarcoidosis
Nabeel Hamzeh · National Jewish Health · funded by National Institutes of Health
2018–2025 · research · R35
Lung Macrophage Programming in Acute Lung Injury
William Janssen · National Jewish Health · funded by National Institutes of Health
2018–2023 · research · R01
Regulation of Gene Expression in the anaphylactic Pathway
Hua Huang · National Jewish Health · funded by National Institutes of Health
2018–2019 · research · R13
Aspen Lung Conference on COPD: Translating Resilience and Pathogenesis to Personalized Therapy for COPD
Irina Petrache · National Jewish Health · funded by National Institutes of Health
2018–2020 · cooperative agreement · U01
Treatment of CGD with the PPAR-gamma agonist, pioglitazone, enhances phagocyte anti-inflammatory and antimicrobial responses
Donna L Bratton · National Jewish Health · funded by National Institutes of Health
2018–2023 · career development · K08
Mannose binding lectin-dependent complement activation in emphysema
Karina Serban · National Jewish Health · funded by National Institutes of Health
2018–2021 · research · R01
Fibroblast Resistance to Apoptosis in Pulmonary Fibrosis
David W. Riches · National Jewish Health · funded by National Institutes of Health
2018–2022 · cooperative agreement · UH3
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis
Gregory Paul Downey · National Jewish Health · funded by National Institutes of Health
2017–2019 · research · Global Health
National Jewish Health - to develop a new method of measuring the effectiveness of tuberculosis treatment in humans
National Jewish Health · funded by Bill and Melinda Gates Foundation
2017–2023 · cooperative agreement · UG1
Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE)
Stanley J. Szefler · National Jewish Health · funded by National Institutes of Health
2017–2022 · research · R01
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution
Moumita Ghosh · National Jewish Health · funded by National Institutes of Health
2017–2024 · cooperative agreement · UM1
National Jewish Health CoFAR Clinical Research Unit
Donald Ym Leung · National Jewish Health · funded by National Institutes of Health
2017–2024 · cooperative agreement · UM1
National Jewish Health CoFAR Clinical Research Unit
Donald Ym Leung · National Jewish Health · funded by National Institutes of Health
2017–2024 · cooperative agreement · UM1
National Jewish Health CoFAR Clinical Research Unit
Donald Ym Leung · National Jewish Health · funded by National Institutes of Health
2017–2023 · cooperative agreement · U01
An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo Nation
Bruce George Bender · National Jewish Health · funded by National Institutes of Health
2017–2023 · cooperative agreement · UG1
Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE)
Stanley J. Szefler · National Jewish Health · funded by National Institutes of Health
2017–2020 · research · R01
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution
Moumita Ghosh · National Jewish Health · funded by National Institutes of Health
2017–2023 · grant · Standard Grant
Unearthing interacting nontuberculous mycobacterial, environmental, and host determinants of lung disease in the Hawai'i Islands
Michael Strong · National Jewish Health · funded by National Science Foundation
2017–2022 · research · R01
Transcriptomic and Pharmacogenetic Asthma Endotypes in Minority Children
Esteban Gonzalez Burchard · National Jewish Health · funded by National Institutes of Health
